JP2003515543A5 - - Google Patents

Download PDF

Info

Publication number
JP2003515543A5
JP2003515543A5 JP2001541010A JP2001541010A JP2003515543A5 JP 2003515543 A5 JP2003515543 A5 JP 2003515543A5 JP 2001541010 A JP2001541010 A JP 2001541010A JP 2001541010 A JP2001541010 A JP 2001541010A JP 2003515543 A5 JP2003515543 A5 JP 2003515543A5
Authority
JP
Japan
Prior art keywords
alkyl
hydrogen
halogen
compound according
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001541010A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003515543A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2000/012009 external-priority patent/WO2001040255A2/en
Publication of JP2003515543A publication Critical patent/JP2003515543A/ja
Publication of JP2003515543A5 publication Critical patent/JP2003515543A5/ja
Pending legal-status Critical Current

Links

JP2001541010A 1999-12-02 2000-11-29 14,15−ベータ−メチレン置換されたアンドロゲン Pending JP2003515543A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL99204080.8 1999-12-02
EP99204080 1999-12-02
PCT/EP2000/012009 WO2001040255A2 (en) 1999-12-02 2000-11-29 14,15-beta-methylene substituted androgens

Publications (2)

Publication Number Publication Date
JP2003515543A JP2003515543A (ja) 2003-05-07
JP2003515543A5 true JP2003515543A5 (cg-RX-API-DMAC10.html) 2008-01-10

Family

ID=8240955

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001541010A Pending JP2003515543A (ja) 1999-12-02 2000-11-29 14,15−ベータ−メチレン置換されたアンドロゲン

Country Status (27)

Country Link
US (1) US6706700B2 (cg-RX-API-DMAC10.html)
EP (1) EP1237904B1 (cg-RX-API-DMAC10.html)
JP (1) JP2003515543A (cg-RX-API-DMAC10.html)
CN (1) CN1166680C (cg-RX-API-DMAC10.html)
AR (1) AR026655A1 (cg-RX-API-DMAC10.html)
AT (1) ATE317396T1 (cg-RX-API-DMAC10.html)
AU (1) AU778017B2 (cg-RX-API-DMAC10.html)
CA (1) CA2390226A1 (cg-RX-API-DMAC10.html)
CO (1) CO5251441A1 (cg-RX-API-DMAC10.html)
CY (1) CY1106086T1 (cg-RX-API-DMAC10.html)
CZ (1) CZ301376B6 (cg-RX-API-DMAC10.html)
DE (1) DE60025958T2 (cg-RX-API-DMAC10.html)
DK (1) DK1237904T3 (cg-RX-API-DMAC10.html)
ES (1) ES2258037T3 (cg-RX-API-DMAC10.html)
HK (1) HK1047596B (cg-RX-API-DMAC10.html)
HU (1) HUP0203611A3 (cg-RX-API-DMAC10.html)
IL (1) IL149424A (cg-RX-API-DMAC10.html)
MX (1) MXPA02004939A (cg-RX-API-DMAC10.html)
NO (1) NO322422B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ518753A (cg-RX-API-DMAC10.html)
PE (1) PE20011033A1 (cg-RX-API-DMAC10.html)
PL (1) PL202999B1 (cg-RX-API-DMAC10.html)
RU (1) RU2242479C2 (cg-RX-API-DMAC10.html)
SK (1) SK287095B6 (cg-RX-API-DMAC10.html)
TW (1) TWI275593B (cg-RX-API-DMAC10.html)
WO (1) WO2001040255A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA200203536B (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2204613T3 (es) * 1999-04-06 2004-05-01 Akzo Nobel N.V. Androgenos 7-alfa alquilo oralmente activos.
EP1470151B1 (en) * 2002-01-21 2009-12-30 N.V. Organon Process for the preparation of 7-alpha-methylsteroids
US20080293683A1 (en) * 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
AU2012320423C1 (en) * 2011-10-07 2018-01-25 Estetra Srl Process for the production of estetrol
CU24523B1 (es) 2015-06-18 2021-06-08 Estetra Sprl Unidad de dosificación orodispersable que contiene un componente estetrol
EP3701944B1 (en) 2015-06-18 2021-12-08 Estetra SRL Orodispersible dosage unit containing an estetrol component
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
MA44206B1 (fr) 2015-06-18 2021-04-30 Estetra Sprl Comprimé orodispersible comprenant estetrol
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
EP3781171B1 (en) 2018-04-19 2022-02-09 Estetra SRL Compounds and their uses for alleviating menopause-associated symptoms
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
CN111621141B (zh) * 2020-06-12 2022-04-08 广西大学 一种缓释型二氧化氯-水性聚氨酯抗菌膜及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3086027A (en) * 1960-01-22 1963-04-16 Lilly Co Eli 19-nor-4, 9(10)-steroids and process
IE60780B1 (en) * 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
DE19537626A1 (de) 1995-10-10 1997-04-17 Jenapharm Gmbh Steroide mit einer 14, 15-Methylengruppe
DE19827522A1 (de) * 1998-06-22 1999-12-23 Jenapharm Gmbh 14,15-Cyclopropanosteroide der 19-Nor-Androstanreihe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
ATE228143T1 (de) 1999-03-08 2002-12-15 Akzo Nobel Nv 14.beta.,17-alpha-hydroxymethylandrostan derivate als androgene

Similar Documents

Publication Publication Date Title
GEP20105066B (en) Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cgmp phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
CA2467222A1 (en) Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
BRPI0512991A (pt) uso de uma progestina, kit farmaceuticamente útil adaptado para a administração oral diária, e, método de contracepção em uma fêmea em idade de parto
MY131522A (en) PHARMACEUTICAL COMPOSITION AND USES FOR ANDROST-5-ENE-3ß,17ß-DIOL
MY126960A (en) Administration of non-oral androgenic steroids to women
EP2067784A3 (en) 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents
JP2010529152A5 (cg-RX-API-DMAC10.html)
EP2108652A3 (en) Process for the preparation of drospirenone
RU2002117440A (ru) Новые андрогены
EP1571153A3 (en) A process for the preparation of drospirenone
JP2005533807A5 (cg-RX-API-DMAC10.html)
CA2467237A1 (en) Method of preventing or treating benign gynaecological disorders
JP2010507685A5 (cg-RX-API-DMAC10.html)
JP2008512426A5 (cg-RX-API-DMAC10.html)
WO2008089093A3 (en) Efficient processes for preparing steroids and vitamin d derivatives with the unnatural configuration at c20 (20 alpha-methyl) from pregnenolone
JP2006507311A5 (cg-RX-API-DMAC10.html)
JP2006508951A5 (cg-RX-API-DMAC10.html)
WO2005077968A8 (en) 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity
JP2009512658A5 (cg-RX-API-DMAC10.html)
JP2009533392A5 (cg-RX-API-DMAC10.html)
JP2002540119A5 (cg-RX-API-DMAC10.html)
CA2504697A1 (en) Methods for treating migraine
WO2001040255A3 (en) 14,15-beta-methylene substituted androgens
IL164159A0 (en) C-17 spirolactonization and 6,7 oxidation of steroids
HUP9903747A2 (hu) Új eljárás mometazon-furoát előállítására